[reaction: see text] A new synthetic procedure for aminohalogenation of olefins has been developed for the preparation of vicinal haloamine derivatives in high yields by using Cu, Mn, or V catalysts with p-toluenesulfonamide (TsNH(2)) and N-bromosuccinimide (NBS) as nitrogen and bromine sources, respectively. Unprecedented regio- and stereoselectivity (anti:syn > 99:1) toward the aminohalogenation process is shown for olefinic substrates as well as transition metal catalysts.
N-Bromosuccinimide efficiently catalyzes the hydroamination and hydroalkoxylation of activated styrenes using tosylamides, carbamates, and alcohols as the nucleophiles to afford amino and ether derivatives, respectively. Both the processes give good to excellent yields of the products with 100% regioselectivity (Markovnikov fashion). [structure: see text]
AminesAmines Q 0120 Transition Metal-Catalyzed Regio-and Stereoselective Aminobromination of Olefins with TsNH 2 and NBS as Nitrogen and Bromine Sources. -Cu, Mn, or V-catalyzed treatment of olefins with Tos-NH2 and NBS offers a new, regio-and stereoselective approach to vicinal aminobromides. The catalysts as well as the nature of the olefinic substituents have important effects on the regiocontrol. -(THAKUR, V. V.; TALLURI, S. K.; SUDALAI*, A.; Org. Lett. 5 (2003) 6, 861-864; Div. Process Dev., Natl. Chem. Lab., Pune 411 008, India; Eng.) -Jannicke 35-072
ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.